Day: July 16, 2020

Houston, July 16, 2020 (GLOBE NEWSWIRE) — Shell Midstream Partners, L.P.’s Second Quarter Earnings Conference Call will be held Friday, July 31 at 10:00am CST. Shell Midstream Partners, L.P.’s participants will be Kevin Nichols, President and Chief Executive Officer, Shawn Carsten, Chief Financial Officer, and Steve Ledbetter, VP Commercial.Financial information, including the earnings release, will be released before markets open on Friday, July 31st. Interested parties may listen to the conference call on the Partnership’s website at www.shellmidstreampartners.com by clicking on the “2020 Second Quarter Financial Results” link in the “Events & Conference” section. A replay of the webcast will be posted on the Partnership’s website following the event.###About Shell Midstream Partners, L.P.Shell Midstream Partners, L.P., headquartered...

MONTREAL, July 16, 2020 (GLOBE NEWSWIRE) — ATW TECH INC. (TSXV: ATW – “ATW” or the “Corporation”). ATW announces that it is unable to file its interim financial statements and accompanying management’s discussion and analysis, and related CEO and CFO certifications, for the period ended March 31, 2020 (the “Interim Filings”), by the filing deadline provided for under the temporary exemption granted under decision N°2020-PDG-0023 issued by the Autorité des marchés financiers (“AMF Temporary Exemption“).ATW has been working diligently and expeditiously with its auditors to file its annual financial statements and accompanying management’s discussion and analysis, and related CEO and CFO certifications, for the year ended December 31, 2019 (the “Annual Filings”) on or before the July 15, 2020 deadline granted by a management...

BROOKFIELD, News, July 16, 2020 (GLOBE NEWSWIRE) — Brookfield Renewable Partners L.P. (“Brookfield Renewable” or “BEP”) (NYSE: BEP; TSX: BEP.UN) today announced that it has set July 27, 2020 as the record date for the previously announced special distribution of class A exchangeable subordinate voting shares (the “Shares”) of Brookfield Renewable Corporation (“BEPC”). From an economic and accounting perspective, the special distribution will be analogous to a unit split as it does not result in any underlying change to aggregate cash flows or net asset value except for the adjustment for the aggregate number of units/shares outstanding.On July 30, 2020, the holders of BEP’s limited partnership units (“BEP units”) of record as of July 27, 2020 will receive one (1) Share of BEPC for every four (4) BEP units held, or 0.25 Shares for...

TORONTO, July 16, 2020 (GLOBE NEWSWIRE) — Generation Mining Limited (TSX: GENM) (OTCQX: GENMF) (“Gen Mining” or the “Company”) announces that it has filed an early warning report (the “Report”) announcing that it has disposed of 4,000,000 common shares (the “Disposed Shares”) of Major Precious Metals Corp. (“MPM”) through a secondary market private share purchase transaction. Prior to the disposition, the Company beneficially owned and controlled, 12,600,000 common shares of MPM. Following the disposition of the Disposed Shares, the Company beneficially owns and controls, 8,600,000 common shares of MPM representing approximately 7.70% of MPM’s issued and outstanding common shares on an undiluted basis.For further information please contact:Jamie LevyPresident and Chief Executive Officer(416) 640-2934(416) 567-2440jlevy@genminin...

TORONTO, July 16, 2020 (GLOBE NEWSWIRE) — CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), announces today, that its Skylight Health Direct Primary Care service will now be available for patients in Florida who have lost healthcare coverage due to job losses during the COVID-19 Pandemic.Skylight Health (“Skylight”) is a Direct Primary Care (“DPC”) that provides unlimited telehealth access for patients seeking urgent and primary care services starting at $16.50 a month ($199/year);Florida is among 5 US States that have seen a dramatic increase in over 5.4 million American uninsured-laid-off workers since the Pandemic started in February 2020; nearly 40% higher than the record set during the recession of 2008/2009;Florida broke the national record for a state’s largest single-day increase in positive cases;Skylight’s...

Lima, July 16, 2020 (GLOBE NEWSWIRE) — Lima, PERU, July 16th, 2020 — Credicorp (NYSE: BAP) announces that in accordance with its corporate disclosure policies and to prevent any leaks of financial results and ensure fairness, the Company will start the quiet period for 2Q20’s earnings release on July Thursday 23th. This period will end on the date of the release, August Thursday 6th. During the quiet period, the Company will not disclose any financial information, comment on financial results, or respond to related questions.About CredicorpCredicorp Ltd. (NYSE: BAP) is the leading financial services holding company in Peru with presence in Chile, Colombia and Bolivia. Credicorp has a diversified business portfolio organized into four lines of business: Universal Banking, through Banco de Credito del Peru – BCP and Banco...

Karolinska Development’s portfolio company Aprea Therapeutics expands clinical trial of eprenetapopt for TP53 mutant Acute Myeloid LeukemiaSTOCKHOLM, SWEDEN – July 16, 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Aprea Therapeutics has decided to expand the enrollment of patients in its Phase 1 clinical trial evaluating eprenetapopt in TP53 mutant Acute Myeloid Leukemia (AML). Following the completion of the safety lead-in portion of the clinical trial, the first expansion cohort will evaluate the combination of eprenetapopt with venetoclax and azacitidine in frontline TP53 mutant AML. Aprea Therapeutics also plans to activate a cohort in the trial that will evaluate eprenetapopt with azacitidine in frontline TP53 mutant AML, expanding upon results for TP53 mutant AML patients recently...

Karolinska Developments portföljföretag Aprea Therapeutics expanderar klinisk studie av eprenetapopt för TP53-muterad akut myeloisk leukemiSTOCKHOLM, SVERIGE 16 juli 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att dess portföljföretag Aprea Therapeutics har beslutat att utöka rekryteringen av patienter i sin kliniska fas 1-studie som utvärderar eprenetapopt i TP53-muterad akut myeloisk leukemi (AML). Efter att en inledande säkerhetutvärdering nu har genomförts i studien kommer den första expansionsgruppen att utvärdera eprenetapopt i kombination med venetoklax och azacitidin som första linjens behandling av TP53-muterad AML. Aprea Therapeutics planerar också att addera en kohort till studien för att utvärdera eprenetapopt i kombination med azacitidin som första linjens behandling av TP53-muterad AML, baserat...

Preliminary second quarter results demonstrate continued momentum in operating and financial performanceBalanced business model, growing originations channels and proven core competency in special servicing position the Company well to deliver profitability and capture growth opportunitiesWEST PALM BEACH, Fla., July 16, 2020 (GLOBE NEWSWIRE) — Ocwen Financial Corporation (NYSE: OCN) (“Ocwen” or the “Company”), a leading non-bank mortgage servicer and originator, today provided preliminary information regarding its second quarter 2020 results and progress on the Company’s key business priorities. A presentation with additional detail regarding today’s announcement is available on the Ocwen Financial Corporation website at www.ocwen.com (through a link on the Shareholder Relations page).The Company reported a net income of $2.0 million...